A pharmaceutical company spent 24 months trying to recruit patients for a phase III clinical trial (TRIAL A). However, at the end of this period, they had only managed to enroll 20% of the patients required by the FDA.
Would you like to learn more about our approach to accelerating patient enrollment for clinical trials?
